Fabian A.
- Country
- Germany
- Department
- Medizinische Klinik II, Haematologie und Medizinische Onkologie
Research Overview
- Evaluation of STX-721 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Specific Mutations
- Phase 3 Study of BAY 2927088 vs. Standard of Care in HER2-Mutant Advanced NSCLC
- Evaluation of Osimertinib Combined with Chemotherapy in First-Line Treatment of Stage IV Non-Small Cell Lung Cancer with Atypical EGFR Mutations
Data & Insights
Has run more than one trial at 40 of 170 partner sites.
Specializations
Lung Cancer Specialization
This investigator specializes in treating non-small cell lung cancer (NSCLC), with particular expertise in managing advanced and metastatic stages of the disease. Their research encompasses various molecular subtypes, including cases with atypical EGFR mutations.
- Stage IV NSCLC treatment approaches
- Non-squamous NSCLC variants
- EGFR mutation analysis and targeting
Their work includes investigation of targeted therapies and innovative treatment combinations for lung cancer patients.
Molecular Oncology
The investigator focuses on molecular-driven cancer treatments, particularly in tumors with specific genetic alterations. Their expertise includes research on SMARCA4 mutations and their impact on cancer progression and treatment response.
- Genetic mutation analysis
- Targeted therapy development
- Biomarker-driven treatment approaches
They investigate novel therapeutic combinations targeting specific molecular pathways in cancer.
Advanced Solid Tumors
The investigator has extensive experience in treating advanced and metastatic solid tumors, including both esophageal cancer and lung malignancies. Their research explores innovative combination therapies including immunotherapy approaches.
- Combination therapy strategies
- Novel therapeutic agents
- Treatment optimization studies
Their work encompasses multi-modal treatment approaches for various advanced cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.